Literature DB >> 25410879

Association of circadian genes with diurnal blood pressure changes and non-dipper essential hypertension: a genetic association with young-onset hypertension.

Hsin-Bang Leu1, Chia-Min Chung2, Shing-Jong Lin3, Kuang-Mao Chiang4, Hsin-Chou Yang5, Hung-Yun Ho6, Chih-Tai Ting6, Tsung-Hsien Lin7, Sheng-Hsiung Sheu7, Wei-Chuan Tsai8, Jyh-Hong Chen8, Wei-Hsian Yin9, Ting-Yu Chiu10, Chin-Iuan Chen10, Cathy Sj Fann5, Yuan-Tsong Chen4, Wen-Harn Pan4, Jaw-Wen Chen11.   

Abstract

Recent studies have suggested that circadian genes have important roles in maintaining the circadian rhythm of the cardiovascular system. However, the associations between diurnal BP changes and circadian genes remain undetermined. We conducted a genetic association study of young-onset hypertension, in which 24-h ambulatory blood pressure (BP) monitoring was performed. A total of 23 tag single-nucleotide polymorphisms (SNPs) on 11 genes involved in circadian rhythms were genotyped for correlations with diurnal BP variation phenotypes. A permutation test was used to correct for multiple testing. Five tag SNPs within five loci, including rs3888170 in NPAS2, rs6431590 in PER2, rs1410225 in RORββ, rs3816358 in BMAL1 and rs10519096 in RORα, were significantly associated with the non-dipper phenotype in 372 young hypertensive patients. A genetic risk score was generated by counting the risk alleles and effects for each individual. Genotyping was performed in an additional independent set of 619 young-onset hypertensive subjects. Altogether, non-dippers had a higher weighted genetic risk score than dippers (1.67±0.56 vs. 1.54±0.55, P<0.001), and the additive genetic risk score also indicated a graded association with decreased diurnal BP changes (P=0.006), as well as a non-dipper phenotype (P=0.031). After multivariable logistic analysis, only the circadian genetic risk score (odds ratio (OR), 1550; 95% confidence interval (CI), 1.225-1.961, P<0.001) and the use of β-blockers (OR, 1.519; 95% CI, 1.164-1.982, P=0.003) were independently associated with the presence of non-dippers among subjects with young-onset hypertension. Genetic variants in circadian genes were associated with the diurnal phenotype of hypertension, suggesting a genetic association with diurnal BP changes in essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25410879     DOI: 10.1038/hr.2014.152

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  55 in total

Review 1.  The mammalian circadian clock.

Authors:  Urs Albrecht; Gregor Eichele
Journal:  Curr Opin Genet Dev       Date:  2003-06       Impact factor: 5.578

2.  TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.

Authors:  Jose C Florez; Kathleen A Jablonski; Nick Bayley; Toni I Pollin; Paul I W de Bakker; Alan R Shuldiner; William C Knowler; David M Nathan; David Altshuler
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

3.  The mammalian clock component PERIOD2 coordinates circadian output by interaction with nuclear receptors.

Authors:  Isabelle Schmutz; Jürgen A Ripperger; Stéphanie Baeriswyl-Aebischer; Urs Albrecht
Journal:  Genes Dev       Date:  2010-02-15       Impact factor: 11.361

Review 4.  Circadian rhythms in the CNS and peripheral clock disorders: function of clock genes: influence of medication for bronchial asthma on circadian gene.

Authors:  Naoto Burioka; Yasushi Fukuoka; Miyako Takata; Masahiro Endo; Masanori Miyata; Hiroki Chikumi; Katsuyuki Tomita; Masahiro Kodani; Hirokazu Touge; Kenichi Takeda; Takashi Sumikawa; Kousuke Yamaguchi; Yasuto Ueda; Hirofumi Nakazaki; Hisashi Suyama; Akira Yamasaki; Hiroyuki Sano; Tadashi Igishi; Eiji Shimizu
Journal:  J Pharmacol Sci       Date:  2007-02-14       Impact factor: 3.337

5.  A comparison of positive family history definitions for defining risk of future disease.

Authors:  S C Hunt; R R Williams; G K Barlow
Journal:  J Chronic Dis       Date:  1986

6.  Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure.

Authors:  Cesare Cuspidi; Stefano Meani; Maurizio Salerno; Cristiana Valerio; Veronica Fusi; Barbara Severgnini; Laura Lonati; Fabio Magrini; Alberto Zanchetti
Journal:  J Hypertens       Date:  2004-02       Impact factor: 4.844

7.  PPARalpha is involved in photoentrainment of the circadian clock.

Authors:  Katsutaka Oishi; Hidenori Shirai; Norio Ishida
Journal:  Neuroreport       Date:  2008-03-05       Impact factor: 1.837

8.  Clinical characteristics of young-onset hypertension-implications for different genders.

Authors:  Jaw-Wen Chen; San-Yu Wu; Wen-Harn Pan
Journal:  Int J Cardiol       Date:  2004-07       Impact factor: 4.164

9.  Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes.

Authors:  Peng Y Woon; Pamela J Kaisaki; José Bragança; Marie-Thérèse Bihoreau; Jonathan C Levy; Martin Farrall; Dominique Gauguier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-29       Impact factor: 11.205

10.  Clock gene expression in peripheral leucocytes of patients with type 2 diabetes.

Authors:  H Ando; T Takamura; N Matsuzawa-Nagata; K R Shima; T Eto; H Misu; M Shiramoto; T Tsuru; S Irie; A Fujimura; S Kaneko
Journal:  Diabetologia       Date:  2008-10-31       Impact factor: 10.122

View more
  17 in total

1.  To overcome two diseases with one pill.

Authors:  Masaki Mogi; Masatsugu Horiuchi
Journal:  Hypertens Res       Date:  2016-01-28       Impact factor: 3.872

2.  Clock Genes Explain a Large Proportion of Phenotypic Variance in Systolic Blood Pressure and This Control Is Not Modified by Environmental Temperature.

Authors:  Hassan S Dashti; Stella Aslibekyan; Frank A J L Scheer; Caren E Smith; Stefania Lamon-Fava; Paul Jacques; Chao-Qiang Lai; Katherine L Tucker; Donna K Arnett; José M Ordovás
Journal:  Am J Hypertens       Date:  2015-06-04       Impact factor: 2.689

3.  The deadly line linking sympathetic overdrive, dipping status and vascular risk: critical appraisal and therapeutic implications.

Authors:  Francesca Santilli; Paola Simeone; Damiano D'Ardes; Giovanni Davì
Journal:  Hypertens Res       Date:  2016-03-17       Impact factor: 3.872

4.  Early Onset Hypertension Is Associated With Hypertensive End-Organ Damage Already by MidLife.

Authors:  Karri Suvila; Elizabeth L McCabe; Arttu Lehtonen; Joseph E Ebinger; Joao A C Lima; Susan Cheng; Teemu J Niiranen
Journal:  Hypertension       Date:  2019-07-01       Impact factor: 10.190

5.  Downregulation of Arntl mRNA Expression in Women with Hypertension: A Case-Control Study.

Authors:  Zhengmei Fang; Lijun Zhu; Yuelong Jin; Yan Chen; Weiwei Chang; Yingshui Yao
Journal:  Kidney Blood Press Res       Date:  2021-09-03       Impact factor: 2.687

6.  Bmal1 in Perivascular Adipose Tissue Regulates Resting-Phase Blood Pressure Through Transcriptional Regulation of Angiotensinogen.

Authors:  Lin Chang; Wenhao Xiong; Xiangjie Zhao; Yanbo Fan; Yanhong Guo; Minerva Garcia-Barrio; Jifeng Zhang; Zhisheng Jiang; Jiandie D Lin; Y Eugene Chen
Journal:  Circulation       Date:  2018-01-25       Impact factor: 29.690

7.  Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients.

Authors:  Sante D Pierdomenico; Anna M Pierdomenico; Francesca Coccina; Domenico Lapenna; Ettore Porreca
Journal:  Hypertens Res       Date:  2016-06-23       Impact factor: 3.872

8.  Assessing genetic risk of hypertension at an early age: future research directions.

Authors:  Xiaoling Wang; Harold Snieder
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-09-12

Review 9.  A role for circadian clock in metabolic disease.

Authors:  Ippei Shimizu; Yohko Yoshida; Tohru Minamino
Journal:  Hypertens Res       Date:  2016-02-18       Impact factor: 3.872

10.  Alcohol suppresses cardiovascular diurnal variations in male normotensive rats: Role of reduced PER2 expression and CYP2E1 hyperactivity in the heart.

Authors:  Mohamed Katary; Abdel A Abdel-Rahman
Journal:  Alcohol       Date:  2020-08-07       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.